Simulating drug penetration during hyperthermic intraperitoneal chemotherapy

Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after debulking cytoreductive surgery. During HIPEC, a limited number of catheters are used to administer and drain fluid containing chemotherapy (41–43 °C), yielding heterogeneities in the perito...

Descripción completa

Detalles Bibliográficos
Autores principales: Löke, Daan R., Helderman, Roxan F. C. P. A., Franken, Nicolaas A. P., Oei, Arlene L., Tanis, Pieter J., Crezee, Johannes, Kok, H. Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808385/
https://www.ncbi.nlm.nih.gov/pubmed/33427507
http://dx.doi.org/10.1080/10717544.2020.1862364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808385/
https://www.ncbi.nlm.nih.gov/pubmed/33427507
http://dx.doi.org/10.1080/10717544.2020.1862364

Ejemplares similares